Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.

Medical Care
Diana L MigliorettiDavid C Grossman

Abstract

Screening for fecal occult blood can be effective in reducing colorectal cancer mortality only if positive tests are appropriately followed up with complete diagnostic evaluation (ie, colonoscopy or flexible sigmoidoscopy with double contrast barium enema) and treatment. To examine whether rates of complete diagnostic evaluation after a positive fecal occult blood test (FOBT) have improved over time after the implementation of tracking systems and physician guidelines within a large integrated health care organization. From 1993 to 2005, 8513 positive FOBTs were identified on 8291 enrollees aged 50-79 of a large health care system. Automated records were used to identify repeat FOBTs, colonoscopy, flexible sigmoidoscopy, and double-contrast barium enema within 1 year after the positive FOBT. National rates of complete diagnostic evaluation were estimated from the 2005 National Health Interview Survey. In this integrated health care organization, the percentage of positive FOBTs followed by complete diagnostic evaluation within 1 year increased from 57-64% in 1993-1996 to 82-86% from 2000-2005. Use of repeat FOBT after a positive FOBT decreased from 28-31% in 1993-1996 to 6-11% in 2000-2005. Based on the National Health Intervie...Continue Reading

References

Nov 1, 1993·American Journal of Public Health·R E MyersL Millner
Apr 1, 1993·American Journal of Epidemiology·F EdererJ S Mandel
Jan 18, 1996·The New England Journal of Medicine·J E AllisonA L Adrain
Feb 1, 1997·Gastroenterology·S J WinawerR J Mayer
Mar 10, 1999·Journal of the National Cancer Institute·J S MandelJ H Bond
Oct 8, 1999·Journal of the National Cancer Institute·J D Lurie, H G Welch
Jan 16, 2002·The Milbank Quarterly·R E GlasgowE H Wagner
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Thomas BodenheimerKevin Grumbach
Oct 17, 2002·JAMA : the Journal of the American Medical Association·Thomas BodenheimerKevin Grumbach
Jan 31, 2003·Gastroenterology·Sidney WinawerUNKNOWN Gastrointestinal Consortium Panel
Sep 23, 2003·The American Journal of Gastroenterology·Nadeem BaigDavid S Weinberg
Mar 17, 2004·Preventive Medicine·Ronald E MyersNeil Schlackman
May 5, 2006·Diseases of the Colon and Rectum·David A EtzioniSteven M Asch
Jun 16, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Deborah A FisherKenneth Fasanella
Oct 13, 2006·The American Journal of the Medical Sciences·Katherine S GarmanDeborah A Fisher
Mar 30, 2007·CA: a Cancer Journal for Clinicians·Robert A SmithHarmon J Eyre

❮ Previous
Next ❯

Citations

Feb 18, 2011·Journal of General Internal Medicine·Linda L HumphreyMark Helfand
Sep 15, 2011·Journal of General Internal Medicine·Melissa R PartinTimothy J Wilt
Sep 17, 2010·Annals of Family Medicine·Joshua J FentonLaura-Mae Baldwin
Sep 9, 2008·Medical Care·Carrie N KlabundeMartin L Brown
Dec 4, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Amit G SingalSamir Gupta
Dec 20, 2011·American Journal of Preventive Medicine·Steven B ZeliadtRuth Etzioni
Oct 5, 2010·Gastrointestinal Endoscopy Clinics of North America·Ann G Zauber
Sep 14, 2010·Best Practice & Research. Clinical Gastroenterology·Iris Lansdorp-VogelaarHermann Brenner
Sep 4, 2015·CA: a Cancer Journal for Clinicians·Manisha VermaRichard C Wender
Jan 1, 2014·International Journal of Cancer. Journal International Du Cancer·Hermann BrennerChristian Stock
Jun 15, 2010·Journal of Vascular Surgery·Carl van WalravenAlan J Forster
May 3, 2016·American Journal of Preventive Medicine·Anne Marie McCarthyUNKNOWN PROSPR consortium
May 28, 2016·Cancer Causes & Control : CCC·David T LissDavid W Baker
Feb 15, 2016·Journal of Community Health·Ann OluloroGloria D Coronado
Mar 5, 2019·Clinical and Translational Gastroenterology·Kevin SelbyDouglas A Corley
Jul 23, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Rebecca A HubbardCarolyn M Rutter
Dec 5, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Melissa R PartinDavid B Nelson
Oct 11, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jada G HamiltonSarah C Kobrin
Feb 5, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jessica ChubakUNKNOWN PROSPR consortium
Dec 31, 2019·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·John M InadomiBeverly B Green
Feb 13, 2021·Israel Journal of Health Policy Research·Revital AzulayAnthony Heymann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.